EnsoData Inc., a Madison health care artificial intelligence startup, got its start in the world of sleep medicine with technology that automates sleep study data to help providers diagnose sleep apnea more quickly and accurately.

Coming off of a recent $20 million Series A capital raise, EnsoData is working to scale that technology worldwide, expand commercial distribution and branch out beyond sleep, EnsoData CEO and co-founder Chris Fernandez said.

Minneapolis-based sleep apnea treatment company Inspire Medical Systems Inc. (NYSE: INSP) was the lead investor in EnsoData’s latest raise, the startup announced June 3. Inspire Medical Systems is also a partner, representing a new type of customer EnsoData is targeting as it grows, Fernandez said.

Click here to read the full article.